Stock ZEAL ZEALAND PHARMA A/S
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Zealand Pharma A/S

Equities

ZEAL

DK0060257814

Market Closed - Nasdaq Copenhagen
Other stock markets
 15:59:36 26/04/2024 BST 		5-day change 1st Jan Change
622 DKK +3.84% Intraday chart for Zealand Pharma A/S +6.60% +66.67%
04-04 U.S. Futures Up, European Stocks Flat as Powell Reiterates Room for Rate Cuts This Year DJ
03-20 Zealand Pharma A/S Approves Appointments to the Board CI

Evolution of the average Target Price on Zealand Pharma A/S

Price target over the last 5 years

History of analyst recommendation changes

4383a2d0000e0c2ea42a8be1.N80zQb_JpkuFuDXWkvOmn8yEU55dyONXqUhssYchW54.Q-BmBtyY8yLt73KB9YDJ2b70DNgo5aYa8DIHw-QRFfRkgmM257HILKj5dA~4e0d3d92e6a801fa8cc37d30b12e4a50

Analyst Recommendations on Zealand Pharma A/S

ZEALAND PHARMA A/S : Goldman Sachs Adjusts Price Target for Zealand Pharma A/S to $42 From $40, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
622 DKK
Average target price
782 DKK
Spread / Average Target
+25.72%
High Price Target
840 DKK
Spread / Highest target
+35.05%
Low Price Target
600 DKK
Spread / Lowest Target
-3.54%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Zealand Pharma A/S

Goldman Sachs

Ratings for Zealand Pharma A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ZEAL Stock
  4. Consensus Zealand Pharma A/S